How about safety? This sentence from a Reuters article on BMS-790052 caught my attention.
Early results of a phase II study presented last week at the European Association for the Study of the Liver in Vienna were also promising. Seven out of eight patients who got the highest dose of the drug had undetectable levels of the virus. The eighth patient had stopped taking the drug for a while.
Market Data 
Markets 
AI
